
Tirzepatide 60mg
39-amino-acid synthetic peptide with C20 fatty diacid modification
CAS: 2023788-19-2
−22.5%
Mean Weight Reduction
SURMOUNT-1, 15mg (NEJM 2022)
2 receptors
Simultaneous Targets
GLP-1 + GIP
Receptor Targets
Technical Data & References
Chemistry, identifiers, and primary literature for Tirzepatide — available as lyophilized powder on Clav Tides.
- Short Sequence
- Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQKAFVQWLIAGGPSSGAPPPS-NH2
- Full Sequence
- Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 (Lys⁰ side-chain modified with γGlu-C20 diacid via AEEA linker)
- Salt Form
- Acetate
- # Amino Acids
- 39
- Purity
- ≥98%
- Molecular Formula
- C225H348N48O68
- Molecular Weight
- 4813.45 g/mol
- CAS Number
- 2023788-19-2
- PubChem CID
- 156588324
- Source
- Synthetic
- Appearance
- Lyophilized powder
- Availability
- Lyophilized powder — Clav Tides
Primary Literature
- 1.
Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018 Dec;18:3-14.
- 2.
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216.
- 3.
Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515.
Research use only. Data compiled from published literature and regulatory registries. Tirzepatide 60mg is supplied for in-vitro laboratory research — not for human consumption, injection, or therapeutic use.
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $359.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds

Retatrutide 30mg

Semaglutide 12mg

Semaglutide 20mg

Semaglutide 30mg
Tirzepatide 60mg
$359.99